179 related articles for article (PubMed ID: 29569971)
1. Src family kinase inhibitor bosutinib enhances retinoic acid-induced differentiation of HL-60 leukemia cells.
MacDonald RJ; Bunaciu RP; Ip V; Dai D; Tran D; Varner JD; Yen A
Leuk Lymphoma; 2018 Dec; 59(12):2941-2951. PubMed ID: 29569971
[TBL] [Abstract][Full Text] [Related]
2. Evidence of off-target effects of bosutinib that promote retinoic acid-induced differentiation of non-APL AML cells.
Kazim N; Yen A
Cell Cycle; 2021 Dec; 20(24):2638-2651. PubMed ID: 34836491
[TBL] [Abstract][Full Text] [Related]
3. GW5074 and PP2 kinase inhibitors implicate nontraditional c-Raf and Lyn function as drivers of retinoic acid-induced maturation.
Jensen HA; Bunaciu RP; Varner JD; Yen A
Cell Signal; 2015 Aug; 27(8):1666-75. PubMed ID: 25817574
[TBL] [Abstract][Full Text] [Related]
4. Roscovitine enhances All-trans retinoic acid (ATRA)-induced leukemia cell differentiation: Novel effects on signaling molecules for a putative Cdk2 inhibitor.
Rashid A; Duan X; Gao F; Yang M; Yen A
Cell Signal; 2020 Jul; 71():109555. PubMed ID: 32032659
[TBL] [Abstract][Full Text] [Related]
5. 6-Formylindolo(3,2-b)Carbazole (FICZ) Modulates the Signalsome Responsible for RA-Induced Differentiation of HL-60 Myeloblastic Leukemia Cells.
Bunaciu RP; Jensen HA; MacDonald RJ; LaTocha DH; Varner JD; Yen A
PLoS One; 2015; 10(8):e0135668. PubMed ID: 26287494
[TBL] [Abstract][Full Text] [Related]
6. The Src-family kinase inhibitor PP2 rescues inducible differentiation events in emergent retinoic acid-resistant myeloblastic leukemia cells.
Jensen HA; Styskal LE; Tasseff R; Bunaciu RP; Congleton J; Varner JD; Yen A
PLoS One; 2013; 8(3):e58621. PubMed ID: 23554907
[TBL] [Abstract][Full Text] [Related]
7. 6-Formylindolo (3,2-b)carbazole (FICZ) enhances retinoic acid (RA)-induced differentiation of HL-60 myeloblastic leukemia cells.
Bunaciu RP; Yen A
Mol Cancer; 2013 May; 12():39. PubMed ID: 23656719
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of c-Cbl and p85 PI3K driven by all-trans retinoic acid and CD38 depends on Lyn kinase activity.
Congleton J; Shen M; MacDonald R; Malavasi F; Yen A
Cell Signal; 2014 Jul; 26(7):1589-97. PubMed ID: 24686085
[TBL] [Abstract][Full Text] [Related]
9. Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide.
Jung YS; Cheong HJ; Kim SJ; Kim KH; Lee N; Park HS; Won JH
Leuk Res; 2014 Aug; 38(8):977-82. PubMed ID: 24953245
[TBL] [Abstract][Full Text] [Related]
10. Src inhibitors, PP2 and dasatinib, increase retinoic acid-induced association of Lyn and c-Raf (S259) and enhance MAPK-dependent differentiation of myeloid leukemia cells.
Congleton J; MacDonald R; Yen A
Leukemia; 2012 Jun; 26(6):1180-8. PubMed ID: 22182854
[TBL] [Abstract][Full Text] [Related]
11. Dasatinib synergizes with ATRA to trigger granulocytic differentiation in ATRA resistant acute promyelocytic leukemia cell lines via Lyn inhibition-mediated activation of RAF-1/MEK/ERK.
Ding M; Weng XQ; Sheng Y; Wu J; Liang C; Cai X
Food Chem Toxicol; 2018 Sep; 119():464-478. PubMed ID: 29097117
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid and 6-formylindolo(3,2-b)carbazole (FICZ) combination therapy reveals putative targets for enhancing response in non-APL AML.
Bunaciu RP; MacDonald RJ; Jensen HA; Gao F; Wang X; Johnson L; Varner JD; Yen A
Leuk Lymphoma; 2019 Jul; 60(7):1697-1708. PubMed ID: 30570341
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acid induces expression of SLP-76: expression with c-FMS enhances ERK activation and retinoic acid-induced differentiation/G0 arrest of HL-60 cells.
Yen A; Varvayanis S; Smith JL; Lamkin TJ
Eur J Cell Biol; 2006 Feb; 85(2):117-32. PubMed ID: 16439309
[TBL] [Abstract][Full Text] [Related]
14. RRD-251 enhances all-trans retinoic acid (RA)-induced differentiation of HL-60 myeloblastic leukemia cells.
Wallace AS; Supnick HT; Bunaciu RP; Yen A
Oncotarget; 2016 Jul; 7(29):46401-46418. PubMed ID: 27331409
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Src family kinases enhances retinoic acid induced gene expression and myeloid differentiation.
Miranda MB; Redner RL; Johnson DE
Mol Cancer Ther; 2007 Dec; 6(12 Pt 1):3081-90. PubMed ID: 18065491
[TBL] [Abstract][Full Text] [Related]
16. Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells.
Remsing Rix LL; Rix U; Colinge J; Hantschel O; Bennett KL; Stranzl T; Müller A; Baumgartner C; Valent P; Augustin M; Till JH; Superti-Furga G
Leukemia; 2009 Mar; 23(3):477-85. PubMed ID: 19039322
[TBL] [Abstract][Full Text] [Related]
17. Salinomycin induces apoptosis and differentiation in human acute promyelocytic leukemia cells.
Zhao Y; Zhong L; Liu L; Yao SF; Chen M; Li LW; Shan ZL; Xiao CL; Gan LG; Xu T; Liu BZ
Oncol Rep; 2018 Aug; 40(2):877-886. PubMed ID: 29989650
[TBL] [Abstract][Full Text] [Related]
18. Sorafenib Inhibition of Mcl-1 Accelerates ATRA-Induced Apoptosis in Differentiation-Responsive AML Cells.
Wang R; Xia L; Gabrilove J; Waxman S; Jing Y
Clin Cancer Res; 2016 Mar; 22(5):1211-21. PubMed ID: 26459180
[TBL] [Abstract][Full Text] [Related]
19. Novel Src/Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src/Abl signaling.
Bieerkehazhi S; Chen Z; Zhao Y; Yu Y; Zhang H; Vasudevan SA; Woodfield SE; Tao L; Yi JS; Muscal JA; Pang JC; Guan S; Zhang H; Nuchtern JG; Li H; Li H; Yang J
Oncotarget; 2017 Jan; 8(1):1469-1480. PubMed ID: 27903968
[TBL] [Abstract][Full Text] [Related]
20. The catalytic DNA topoisomerase II inhibitor ICRF-193 and all-trans retinoic acid cooperatively induce granulocytic differentiation of acute promyelocytic leukemia cells: candidate drugs for chemo-differentiation therapy against acute promyelocytic leukemia.
Niitsu N; Higashihara M; Honma Y
Exp Hematol; 2002 Nov; 30(11):1273-82. PubMed ID: 12423680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]